Dublin, Oct. 21, 2022 (GLOBE NEWSWIRE) — The “Healthcare BPO Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the global healthcare bpo market.
The global healthcare BPO market is expected to grow from $247.26 billion in 2021 to $277.24 billion in 2022 at a compound annual growth rate (CAGR) of 12.1%. The healthcare BPO market is expected to grow to $441.08 billion in 2026 at a CAGR of 12.3%.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Major players in the healthcare BPO market are Accenture, Cognizant, Tata Consultancy Services, Genpact, HCL Business Services, IQVIA, IBM Corporation, GeBBS Healthcare Solutions, Xerox Corporation, NTT Data Corporation, Infosys BPM, Firstsource Solutions, Omega Healthcare, Invensis and Wipro.
The healthcare BPO market consists of sales of healthcare business process outsourcing services by entities (organizations, partnerships, and sole proprietors) that include the practice of healthcare organizations outsourcing non-core business activities to outside vendors. Outsourced business activities or processes that provide administrative or other support to medical institutions, staff, and organizations are referred to as healthcare BPOs. Coding, billing services, transcription, and other similar tasks are frequently outsourced by healthcare institutions to BPO providers.
The main services provided by healthcare BPO are revenue cycle management; patient enrollment and strategic planning and patient care. Revenue cycle management (RCM) is the financial process that healthcare facilities use to track patient care episodes from registration and appointment scheduling to the final payment of a balance using medical billing software. The various payer services include human resource management, claims management, customer relationship management (CRM), operational/administrative management, care management, provider management, and other payer services that are used by pharmaceutical companies for research and development, manufacturing, and non-clinical service.
North America was the largest region in the healthcare BPO market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare BPO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The healthcare BPO market research report is one of a series of new reports that provides healthcare BPO market statistics, including healthcare BPO industry global market size, regional shares, competitors with a healthcare BPO market share, detailed healthcare BPO market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare BPO industry. This healthcare bpo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The rapid increase of clinical process outsourcing is significantly driving the growth of the healthcare BPO market. Clinical process outsourcing is administrative work in the healthcare industry that requires or benefits from clinical expertise. The increase in the increase of clinical trials outsourcing is due to the rise in a number of drugs entering clinical phases and the companies that are slashing their workforce look for CROs to help them manage their portfolios.
Technology advancements are shaping the healthcare BPO market. The key players in the healthcare BPO market are focusing on innovating the outsourced services and expanding their scope of application to gain their market position. For instance, in May 2020, IQVIA, an American health information technology company, launched HCP/HCO Engagement Management. It is a completely orchestrated healthcare professional/organization (HCP/HCO) solution that lets users plan, manage, contract, and pay HCP/HCOs anywhere in the world. HCP/O Engagement Management is a transformative technology that integrates with customers’ existing IT ecosystems and adapts to how they do business.
In January 2022, Betaine BV, affiliated with Baring Private Equity Asia (BPEA), a Hong Kong-based Asian private equity firm acquired Hinduja Global Solutions (HGS) Limited for $1,200 million enterprise value. Through this acquisition, HGS will strategically invest in building its technology capabilities to support the company’s future growth. Hinduja Global Solutions (HGS) Limited is an Indian company that specializes in business process management (BPM) and customer experience optimization in healthcare.
The countries covered in the healthcare BPO market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Key Topics Covered:
1. Executive Summary
2. Healthcare BPO Market Characteristics
3. Healthcare BPO Market Trends And Strategies
4. Impact Of COVID-19 On Healthcare BPO
5. Healthcare BPO Market Size And Growth
5.1. Global Healthcare BPO Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Healthcare BPO Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Healthcare BPO Market Segmentation
6.1. Global Healthcare BPO Market, Segmentation By Provider Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Revenue Cycle Management
Patient Enrollment And Strategic Planning
Patient Care
6.2. Global Healthcare BPO Market, Segmentation By Payer Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Human Resource Management
Claims Management
Customer Relationship Management (CRM)
Operational/Administrative Management
Care Management
Provider Management
Other Payer Services
6.3. Global Healthcare BPO Market, Segmentation By Pharmaceutical Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Research And Development
Manufacturing
Non-clinical Service
7. Healthcare BPO Market Regional And Country Analysis
7.1. Global Healthcare BPO Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Healthcare BPO Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/y7cax4
Shares of fuel cell manufacturer FuelCell Energy (NASDAQ: FCEL) tanked in early trading on the Nasdaq Tuesday, falling 8.4% through 10:30 a.m. EST after the company missed badly on its Q4 2022 earnings report. Heading into earnings day, analysts had forecast that FuelCell would book $43.8 million in sales and lose only $0.07 per share on that revenue — but FuelCell missed on both the top and bottom lines. While FuelCell missed Wall Street's quarterly sales number, its sales still jumped more than 180% year over year for the quarter, capping a year in which total 2022 sales grew 88% ($130.5 million).
IceCure Medical, a little-known medical device company surged in after-hours trading Monday. IceCure's Prosense technology proved to be a safe and effective treatment for cancerous kidney tumors.
In this video, I will talk about Tesla (NASDAQ: TSLA), some new price targets from analysts, the damage that the Twitter acquisition has caused, and what investors should know going into 2023. For the full insights, watch the video, consider subscribing, and click the special offer link below.
These rock-solid income stocks, with inflation-fighting yields ranging from 4.6% to 8%, provide plenty of reward with minimal risk for investors.
Yahoo Finance Live breaks down the action surrounding Moderna after Jefferies analysts upgraded its stock and price target.
In early afternoon Tuesday trading, shares of marijuana stocks are taking another tumble — their second day in a row of negative returns. Less visible, OTC-listed stocks like Curaleaf Holdings (OTC: CURLF) and Cresco Labs (OTC: CRLBF) are suffering a bit less, down 3.5% and 3.7%, respectively. All three stocks, however, have just one catalyst to blame for their troubles: Congress.
Congress is on the verge of passing a bill that aims to help Americans save more for retirement, including raising the age people must start withdrawing money from tax-deferred retirement accounts.
Many investors, subsequently, try to offset their losses by turning to high-yield dividend stocks. The mortgage real estate investment trust (mREIT) Annaly Capital Management (NYSE: NLY) is one of the highest-yielding stocks in the market today, paying a juicy 16% dividend yield. Annaly Capital Management invests in mortgages and mortgage-backed securities (MBS) in addition to servicing loans for other mortgage companies.
These include increasing the age for required minimum distributions from retirement plans to pushing businesses to get more employees enrolled in plans.
The Philadelphia cell therapy developer suffered a major setback last year when two patients died in a clinical trial testing the company's prostate cancer cell therapy.
Holding out hope for clear skies in real estate? You may be waiting a while.
Yahoo Finance Live anchors discuss the rise in Lucid stock following the EV maker’s $1.5 billion stock sale.
Shares of companies tied to the electric car industry, from start-up EV manufacturer Faraday Future Intelligent Electric (NASDAQ: FFIE) to Blink Charging (NASDAQ: BLNK) and ChargePoint (NYSE: CHPT) — which, as their names suggest, both operate networks of chargers for electric cars — tumbled in early trading Monday. As of 10:45 a.m. ET, Faraday shares are down a disheartening 11.7%, while Blink is losing 6% and ChargePoint has been drained by 8.5%. Given that there's no obviously negative news on the wires about any of these companies today, however, there seems only one logical explanation for the selling: tax loss harvesting.
How she job-hopped her way to half a million dollars in pay while also finding more time to spend with her family.
Gilead and Arcus toppled Tuesday after their lung-cancer regimen trailed a rival concoction from Roche. RCUS stock skidded more than 20%.
What happened It wasn't exactly a Marijuana Monday for pot sector stocks on the first trading day of this week. Many got hammered during the session, with U.S. multi-state operators Curaleaf (OTC: CURLF) and Green Thumb Industries (OTC: GTBIF) falling at double-digit rates of 17% and 12%, respectively.
A look at the shareholders of The Bank of N.T. Butterfield & Son Limited ( NYSE:NTB ) can tell us which group is most…
The average brokerage recommendation (ABR) for Energy Transfer LP (ET) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
The big market headline this year – all year – has been the steady fall in stocks. The S&P 500 is down 20% for 2022, and the NASDAQ has fallen a disastrous 33%. And while recent data shows that there may be some hope on the inflation front, there may still be storm clouds massing for next year’s stock market. That’s the view of Mike Wilson, Morgan Stanley's chief equity strategist. He’s been a leading voice among the bears this year, and he’s not changing that tune as we head into the New Year.
Madrigal's (MDGL) phase III MAESTRO-NASH study evaluating resmetirom for treating nonalcoholic steatohepatitis and liver fibrosis meets both primary endpoints. Stock rises.